Home Amines 127910-32-1
127910-32-1,MFCD00882474
Catalog No.:AA019FQM

127910-32-1 | (E)-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥99%
in stock  
$216.00   $152.00
- +
10mg
≥99%
in stock  
$302.00   $212.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA019FQM
Chemical Name:
(E)-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic acid
CAS Number:
127910-32-1
Molecular Formula:
C8H16NO5P
Molecular Weight:
237.1901
MDL Number:
MFCD00882474
SMILES:
CCOC(=O)C(/C=C(/CP(=O)(O)O)\C)N
Properties
Computed Properties
 
Complexity:
295  
Covalently-Bonded Unit Count:
1  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
1  
XLogP3:
-3.4  

Literature

Title: An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.

Journal: Psychopharmacology 20110101

Title: Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101

Title: Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20060125

Title: The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.

Journal: The Journal of pharmacology and experimental therapeutics 20041101

Title: Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Journal: Psychopharmacology 20040801

Title: Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.

Journal: Polish journal of pharmacology 20040101

Title: Nitric oxide is involved in nicotine-induced burst firing of rat ventral tegmental area dopamine neurons.

Journal: Neuroscience 20040101

Title: NMDA receptor-dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development.

Journal: The European journal of neuroscience 20021001

Title: Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures.

Journal: Psychopharmacology 20020901

Title: Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.

Journal: Neuropharmacology 20010301

Title: Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist.

Journal: Psychopharmacology 19980401

Title: Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.

Journal: Brain research 19950206

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 127910-32-1
Tags:127910-32-1 Molecular Formula|127910-32-1 MDL|127910-32-1 SMILES|127910-32-1 (E)-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic acid